THE IMPORTANCE OF DETERMINING THE UROMODULIN SERUM CONCENTRATION IN DIABETES MELLITUS TYPE 2 PATIENTS
Introduction: In the kidney, cells in the thick ascending limb of the loop of the Henle synthesized uromodulin (UMOD). This study aims to present the evaluation of the uromodulin serum concentration in diabetes mellitus type 2 (T2DM) patients in the early detection of kidney damage.
Materials and methods: The study included 50 T2DM patients with a mean age of 60.75±11.23 years with estimated glomerular filtration rate (eGFR) 114.38±22.12 ml/min and a control group of 20 healthy persons. We measured serum concentration of haemoglobin, urea, creatinine, uromodulin (ELISA method), and cystatin C (nephelometry). We determined formulas: Cockcroft-Gault# (combination Cockcroft- Gault for patients with BMI< 30 kg/m2 and Cockcroft- GaultLBW for patients with BMI≥ 30 kg/m2), CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration equation), and simple Cystatin C.
Results: T2DM patients had lower hemoglobin serum concentration as well as eGFR calculated by formulas: Cockcroft- Gault# and CKD-EPI. T2DM patients had significantly higher BMI and cystatin C compared to control group. T2DM patients had significantly lower serum uromodulin concentration (136.51±84.34 vs 220.50±92.39 ng/ml) than in controls. Significant positive correlation between uromodulin and Cockcroft- Gault# (r= 0.432, p= 0.000), CKD- EPI (r = 0.439; p = 0.000) formulas as well as simple cystatin C (r = 0.250, p = 0.02), but negative correlation with age (r = -0.476, p =0.000), BMI (r = -0.313, p = 0.002) and cystatin C serum concentration (r = -0.293, p = 0.015) were found.
Conclusion: The role of serum uromodulin concentration is not still fortified. The results of this study showed that reduced uromodulin serum concentration indicated early kidney damage in T2DM patients.
Micanovic R, LaFavers K, Garimella P, Wu X, El-Achkar TM. Uromodulin (Tamm- Horsfall protein guardian of urinary and systemic homeostasis). Nephrol Dial Transplant. 2020; 35(1):33-43. doi: 10.1093/ndt/gfy394.
Kipp A, Olinger E. What does uromodulin do? Clin J Am Soc Nephrol. 2020 ;16(1):150-3. doi: 10.2215/CJN.06390420
El- Achkar TM, Wu XR. Uromodulin in kidney injury: an instigator, bystander, or protector ? Am J Kidney Dis. 2012; 59 (3): 452- 61.doi:10.1053/j.ajkd.2011.10.054.
Leiherer A, Muendlein A, Saely CH, Kinz E, Brandtner EM, Fraunberger P et al. Serum uromodulin is associated with impaired glucosae metabolism. Medicine (Baltimore). 2017; 96 (5): e5798. doi: 10.1097/MD.0000000000005798.
Xu X, Barreiro K, Musante L, Kretz O, Lin H, Zou H et al. Management of Tamm- Horsfall Protein for reliable urinary analytics. Proteomics Clin Appl. 2019;13(6):e1900018. doi: 10.1002/prca.201900018.
Sӓemann MD, Weichart T, Zeyda M, Staffler G, Schunn M, Stuhlmeier KM et al. Tamm–Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest. 2005; 115: 468–75. doi: 10.1172/JCI22720.
Pfistershammer K, Klauser C, Leitner J, Stӧckl J, Maidic O, Weichhart T et al. Identification of the scavenger receptors SREC-I, Cla- 1 (SR-BI), and SR- AI as cellular receptors for Tamm- Horsfall protein. J Leukoc Biol. 2008; 83 (1): 131- 8. doi:10.1189/jlb.0407231.
Lou NJ, Ni YH, Jia HY, Deng JT, Jiang L, Zheng FJ et al. Urinary microvesicle- bound uromodulin: a potential molecular biomarker in diabetic kidney disease. J Diabetes Res. 2017; 2017:3918681. doi: 10.1155/2017/3918681.
Leiherer A, Muendlein A, Saely CH, Brandtner EM, Geiger K, Fraunberger P et al. The value of uromodulin as a new serum marker to predict decline in renal function. J Hypertens. 2018; 36(1): 110-8. doi: 10.1097/HJH.0000000000001527.
Lhotta K. Uromodulin and chronic kidney disease. Kidney Blood Press Res. 2010; 33(5): 393- 8. doi:10.1159/000320681.
Magder S. Volume and its relationship to cardiac output and venous return. Crit Care. 2016; 20(1): 271. doi: 10.1186/s13054-016-1438-7.
Shahbaz H, Gupta M. Ceatinine Clearance [Updated 2021 Jul 26]. In: StatPearls [Internet].Treasure Island (FL): Stat Pearls Publishing; 2021 Jan.
Rhee J, Kwon JM, Han SH, Kim SH, Park CH, Jeon JH et al. Cockcroft-Gault, modification of diet in renal disease, and chronic kidney disease epidemiology collaboration equations for estimating glomerular filtration rates in cancer patients receiving cisplatin-based chemotherapy. Kidney Res Clin Pract. 2017;36(4):342-8.doi.org/10.23876/j.krcp.2017.36.4.342.
Friesen JHP. Propofol pharmacokinetic model and lean body weight scalar for dose estimation in morbid obesity. Br J Anaesth. 2019; 123(2): e159-e160. doi: 10.1016/j.bja.2019.04.047.
Zafari N, Churilov L, Maclaac R, Tourkami N, Baxter H, Kiburg K et al. Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systemic review and meta-analysis protocol. BMJ Open 2019; 9:e031558. doi:10.1136/bmjopen-2019-031558.
Inker LA, Eneanya JC, Coresh J, Tighiouart H, Wang D, Sang Y et al. New creatinine - and cystatin C- based equations to estimate GFR without race. N Engl J Med. 2021; 385(19):1737-49. doi: 10.1056/NEJMoa2102953.
Bachmann S, Koeppen- Hagemann I, Kriz W. Ultrastructural localization of Tamm- Horsfall glycoprotein (THP) in rat kidney as revealed by protein A-gold immunocytochemistry. Histochemistry. 1985; 83(6): 531- 8. doi: 10.1007/BF00492456.
Jennings P, Aydin S, Kotanko P, Lechner J, Lhotta K, Williams S et al. Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy. J Am Soc Nephrol. 2007; 18 (1): 264- 73.
Risch L, Lhotta K, Meier D, Medina-Escobar P, Nydegger UE, Risch M. The serum uromodulin level associated with kidney function. Clin Chem Lab Med.2014;52 (12):1755-61. doi: 10.1515/cclm-2014-0505.
Thornley C, Dawnay A, Cattell WR. Human Tamm- Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by fully validated radioimmunoassay. Clin Sci. 1985; 68 (5): 529- 35. doi:10.1042/cs0680529.
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985; 33(4): 278-85. doi: 10.111/j.1532-5415.1985.tb07117.x.
Dawnay AB, Cattel WR. Serum Tamm- Horsfall glycoprotein levels in health and renal disease. Clin Nephrol. 1981; 15(1): 5- 8.
Prajczer S, Heidenreich U, Pfaller W, Kotanko P, Lhotta K, Jennings P. Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant. 2010; 25(6): 1896-903. doi: 10.1093/ndt/GFP 748.
- There are currently no refbacks.
Copyright (c) 2021 Elena Jordanova, Vladimir Samardzic, Gordana Pekovic-Perunicic, Jelena Tica-Jevtic, Sanja Simic-Ogrizovic
This work is licensed under a Creative Commons Attribution 4.0 International License.